Burkitt's lymphoma: cell kinetics, treatment and immunology.
D000912:Antibodies, Neoplasm / Q000032:analysis; D000914:Antibodies, Viral / Q000032:analysis; D002051:Burkitt Lymphoma / Q000175:diagnosis / Q000188:drug therapy; D046508:Culture Techniques; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007278:Injections, Spinal; D008727:Methotrexate / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011379:Prognosis; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014750:Vincristine / Q000627:therapeutic use
D000912:Antibodies, Neoplasm; D000914:Antibodies, Viral; D003561:Cytarabine; D014316:Tritium; D014750:Vincristine; D003520:Cyclophosphamide; D013936:Thymidine; D008727:Methotrexate